scholarly journals Using the age-based insurance eligibility criterion to estimate moral hazard in medical care consumption

2016 ◽  
Vol 40 (3) ◽  
pp. 337-356 ◽  
Author(s):  
Yan Zheng ◽  
Tomislav Vukina
Keyword(s):  
Moral Hazard ◽  
Medical Care ◽  
Eligibility Criterion

scholarly journals The COVID-19 Run on Medical Resources in Wuhan China: Causes, Consequences and Lessons

Healthcare ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1362
Author(s):  
Gaofeng Yin ◽  
Hanning Song ◽  
Jian Wang ◽  
Stephen Nicholas ◽  
Elizabeth Maitland
Keyword(s):  
Moral Hazard ◽  
Medical Care ◽  
Medical Insurance ◽  
Regulatory Control ◽  
Health Providers ◽  
Medical Resource ◽  
Lender Of Last Resort ◽  
Medical Care System ◽  
Medical Resources ◽  
High Level

The COVID-19 run on medical resources crashed Wuhan’s medical care system, a medical disaster duplicated in many countries facing the COVID-19 pandemic. In a novel approach to understanding the run on Wuhan’s medical resources, we draw from bank run theory to analyze the causes and consequences of the COVID-19 run on Wuhan’s medical resources and recommend policy changes and government actions to attenuate runs on medical resources in the future. Like bank runs, the cause of the COVID-19 medical resource run was rooted in China’s local medical resource context and a sudden realignment of expectations, reflecting shortages and misallocations of hospital resources (inadequate liquidity and portfolio composition); high level hospitals siphoning-off patients from lower level health providers (bank moral hazard and adverse selection problem); patients selecting high-level hospitals over lower-level health care (depositor moral hazard problem); inadequate government oversight and uncontrolled risky hospital behavior (inadequate bank regulatory control); biased medical insurance schemes (inadequate depositor insurance); and failure to provide medical resource reserves (failure as lender of last resort). From Wuhan’s COVID-19 run on medical resources, we recommend that control and reform by government enlarge medical resource supply, improve the capacity of primary medical care, ensure timely virus information, formulate principles for the allocation of medical resources that suit a country’s national conditions, optimize the medical insurance schemes and public health fund allocations and enhance the emergency support of medical resources.

Adverse selection and moral hazard in the provision of clinical trial ancillary care

2012 ◽  
Vol 8 (2) ◽  
pp. 225-234 ◽  
Author(s):  
Michael R. Richards ◽  
Lorens A. Helmchen
Keyword(s):  
Clinical Trial ◽  
Moral Hazard ◽  
Medical Care ◽  
Adverse Selection ◽  
Financial Risk ◽  
Third Party ◽  
Care Utilization ◽  
Insurance Benefit ◽  
Ancillary Care ◽  
Study Participants

AbstractAs more and more clinical trials are conducted in developing countries, concerns arise about non-trial medical care available to study participants. Recent work argues for ancillary care – medical care not part of the clinical trial per se – to be formally incorporated into these studies. Although the provision of ancillary care is often justified on ethical grounds, a number of crucial implementation issues remain unresolved, including its scope, duration and financing. Drawing on lessons from health insurance benefit design, we highlight two overlooked challenges for ancillary care adoption – adverse selection and moral hazard – and offer recommendations that could attenuate their consequences. Specifically, adverse selection and moral hazard could be reduced by offering a choice between ancillary medical care and monetary compensation or rewarding low ancillary care utilization. Alternatively, researchers’ financial risk due to ancillary care could be shifted to a third-party insurer. Recognizing participants’ behavioral responses to prospective offers of ancillary medical care would allow funders and research teams to forecast the demand for ancillary care more accurately and to prepare for its provision more adequately.

Beneficial Moral Hazard and the Theory of the Second Best

2009 ◽  
Vol 46 (2) ◽  
pp. 229-240 ◽  
Author(s):  
Kevin D. Frick ◽  
Michael E. Chernew
Keyword(s):  
Health Insurance ◽  
Moral Hazard ◽  
Medical Care ◽  
Market Power ◽  
Economic Efficiency ◽  
Second Best ◽  
Welfare Consequences

This article examines the welfare consequences of moral hazard, and brings together several arguments suggesting that, in many cases, the additional consumption associated with health insurance could be welfare enhancing. Since conditions for maximum economic efficiency fail to hold in the market for medical care, the theory of the second best is useful. We focus on three efficiency-related reasons why insurance-induced consumption may improve welfare: 1) insurance can offset market power; 2) insurance can remedy some externalities; and 3) insurance can mitigate problems that are associated with misinformation and result in the underutilization of many types of care. These arguments strengthen the case for expanding coverage.

The Collaborative Medical and Behavioral Management of Chronic Cough

2009 ◽  
Vol 19 (2) ◽  
pp. 49-57
Author(s):  
Brian E. Petty ◽  
Seth H. Dailey
Keyword(s):  
Medical Care ◽  
Chronic Cough ◽  
Therapeutic Management ◽  
Ambulatory Setting ◽  
Behavioral Management ◽  
Speech Language Pathologists ◽  
Speech Language Pathologist ◽  
The Many ◽  
Frequent Reason

Abstract Chronic cough is the most frequent reason cited by patients for seeking medical care in an ambulatory setting and may account for 10% to 38% of a pulmonologist's practice. Because chronic cough can be caused by or correlated with a wide array of disorders and behaviors, the diagnosis of etiologic factors and determination of appropriate therapeutic management in these cases can prove to be daunting for the physician and speech-language pathologist alike. This article will describe the phenomenon of chronic cough, discuss the many etiologic factors to consider, and review some of the more common ways in which speech-language pathologists and physicians collaborate to treat this challenging condition.

Clinical trials screening: An opportunity to increase medical care access

2001 ◽  
Vol 120 (5) ◽  
pp. A410-A410
Author(s):  
T KOVASC ◽  
R ALTMAN ◽  
R JUTABHA ◽  
G OHNING
Keyword(s):  
Clinical Trials ◽  
Medical Care ◽  
Care Access
Sign in / Sign up

Export Citation Format

Share Document